Key Record Dates
ClinicalTrials.gov Identifier: | NCT03875729 |
---|---|
Brief Title: | Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT) |
First Submitted : | March 13, 2019 |
First Submitted that Met QC Criteria : | March 13, 2019 |
First Posted : | March 15, 2019 |
Results First Submitted : | February 8, 2024 |
Results First Posted with QC Comments : | March 6, 2024 |
Results First Submitted that Met QC Criteria : | March 27, 2024 |
Results First Posted : | April 24, 2024 |
Last Update Submitted that Met QC Criteria : | March 27, 2024 |
Last Update Posted : | April 24, 2024 |